Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.07	25.8	28.68	15.36	90.54	105.14
Short-Term Investments	12.42	33.48	51.73	69.49	67.04	103.35
Cash & Short-Term Investments	55.49	59.28	80.41	84.85	157.58	208.49
Cash Growth	-21.73%	-26.27%	-5.24%	-46.15%	-24.42%	-46.67%
Receivables	81.05	78.88	60.14	52.05	35.5	41.85
Inventory	70.03	53.16	42.11	54.57	48.38	41.91
Prepaid Expenses	22.84	17.69	6.12	13.96	12.96	21.95
Total Current Assets	229.4	209.01	188.77	205.44	254.42	314.2
Property, Plant & Equipment	13.67	17.65	25.6	29.81	33.56	39.01
Other Long-Term Assets	5.88	6.48	8.13	15.71	17.72	0.35
Total Assets	248.95	233.15	222.51	250.95	305.71	353.56
Accounts Payable	12.02	11.71	3.24	3.23	3.8	0.53
Accrued Expenses	72.42	76.71	73.37	76.44	62.26	89.22
Short-Term Debt	-	-	-	-	-	7.05
Current Portion of Leases	0.78	3.04	3.08	2.69	2.42	3
Other Current Liabilities	4.49	-	-	-	2.58	2.7
Total Current Liabilities	89.71	91.46	79.69	82.36	71.06	102.5
Long-Term Debt	139.66	174.73	173.75	149.28	149.08	-
Long-Term Leases	-	-	2.8	5.5	8	14.56
Other Long-Term Liabilities	4.69	0.62	0.24	0.24	-	-
Total Liabilities	234.07	266.8	256.48	237.38	228.14	117.06
Common Stock	1.83	1.52	1.5	1.19	1.02	0.91
Additional Paid-In Capital	1,942	1,884	1,871	1,808	1,690	1,628
Retained Earnings	-1,937	-1,920	-1,906	-1,795	-1,613	-1,393
Comprehensive Income & Other	-	0.01	0.01	-0.02	-0.01	0.26
Shareholders' Equity	14.89	-33.65	-33.97	13.57	77.57	236.49
Total Liabilities & Equity	248.95	233.15	222.51	250.95	305.71	353.56
Total Debt	140.44	177.76	179.63	157.48	159.5	24.61
Net Cash (Debt)	-84.96	-118.48	-99.22	-72.63	-1.92	183.88
Net Cash Growth	-	-	-	-	-	-50.46%
Net Cash Per Share	-0.54	-0.78	-0.72	-0.67	-0.02	2.03
Filing Date Shares Outstanding	183.36	152.33	150.33	119.26	102.14	91.4
Total Common Shares Outstanding	183.32	152.13	150.29	119.16	102.01	91.31
Working Capital	139.69	117.56	109.09	123.08	183.37	211.69
Book Value Per Share	0.04	-0.22	-0.23	0.11	0.76	2.59
Tangible Book Value	7.02	-33.65	-33.97	13.57	77.57	236.49
Tangible Book Value Per Share	0.04	-0.22	-0.23	0.11	0.76	2.59
Machinery	-	32.4	36.55	35.81	36.37	32.73
Leasehold Improvements	-	0.31	0.65	0.65	0.61	0.88

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q